Product
SUNPG1623
1 clinical trial
1 indication
Indication
Psoriatic ArthritisClinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Phase 2b Study to Demonstrate the Safety and Efficacy of Tildrakizumab in Subjects With Active Psoriatic ArthritisStatus: Completed, Estimated PCD: 2019-03-01